skip to main content

Research + Education

The University of Michigan Rogel Cancer Center has a distinguished history of scientific excellence, collaboration and impact in basic science, clinical research and cancer control research.

News

  • Menthol cigarettes are difficult to quit. What would make it easier?

    Menthol cigarettes are designed to make it easier to start smoking and harder to quit. In Michigan, 40% of callers to the state’s Tobacco Quitline are menthol users. Now, a new partnership between the University of Michigan Rogel Cancer Center and the Quitline will develop and test strategies to help menthol users kick the habit.
    Read More >
  • Daniel Chang to lead Department of Radiation Oncology at Michigan Medicine

    Daniel Chang, M.D., was named chair of the Department of Radiation Oncology at Michigan Medicine. The University of Michigan Board of Regents approved the appointment at its Sept. 22 meeting. Chang, who is currently the Sue and Bob McCollum Professor of Radiation Oncology at Stanford University, will begin at U-M on Oct. 1.
    Read More >
  • Mathematics enable scientists to understand organization within a cell’s nucleus

    Rogel researchers have developed a new mathematical technique to begin to understand how a cell’s nucleus is organized. The technique, tested on several types of cells, revealed what the researchers termed self-sustaining transcription clusters, a subset of proteins that play a key role in maintaining cell identity. They hope this understanding will expose vulnerabilities that can be targeted to reprogram a cell to stop cancer or other diseases.
    Read More >
  • U-M’s Colorful event celebrates progress in cancer research

    The second annual Colorful event is an evening of celebration and support of cancer research at the Rogel Cancer Center, the No. 1 ranked cancer program in Michigan. The evening will include both in-person and virtual options. Colorful will be a talk-show-style event hosted by NFL alums Dhani Jones with special guest Devon Still, and will include comments from Rogel researchers and patients.
    Read More >